Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization

Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization

The wet type of age-related macular degeneration (AMD) accompanies the subfoveal choroidal neovascularization (CNV) caused by the abnormal extension or remodeling of blood vessels to the macula and retinal pigment epithelium (RPE). Vascular endothelial growth factor (VEGF) is known to play a crucial...

Celý popis

Podrobná bibliografie
Hlavní autoři: E Seul Kim, Min Sang Lee, Hayoung Jeong, Su Yeon Lim, Doha Kim, Dahwun Kim, Jaeback Jung, Siyan Lyu, Hee Joo Cho, Dong Min Kim, Wonhee Suh, Ji Hoon Jeong
Médium: Článek
Jazyk:English
Vydáno: MDPI AG 2021-09-01
Edice:Pharmaceutics
Témata:
rivoceranib
drug repositioning
microsphere
subfoveal choroidal neovascularization
macular degeneration
On-line přístup:https://www.mdpi.com/1999-4923/13/10/1548

Internet

https://www.mdpi.com/1999-4923/13/10/1548

Podobné jednotky